EP 1011681 A1 20000628 - ORAL CONTRACEPTIVE PREPARATION HAVING A FIRST PHASE COMPRISING PROGESTIN/ESTROGEN AND A SECOND PHASE COMPRISING PROGESTIN
Title (en)
ORAL CONTRACEPTIVE PREPARATION HAVING A FIRST PHASE COMPRISING PROGESTIN/ESTROGEN AND A SECOND PHASE COMPRISING PROGESTIN
Title (de)
ORALE KONTRAZEPTIVE ZUBEREITUNG ENTHALTEND EINE ERSTE PHASE ENTHALTENDE EINE KOMBINATION VON GESTAGEN/ESTROGEN UND EINE ZWEITE PHASE ENTHALTEND GESTAGEN
Title (fr)
PREPARATION CONTRACEPTIVE ORALE COMPORTANT UNE PREMIERE PHASE A BASE DE PROGESTINE/OESTROGENE ET UNE SECONDE PHASE A BASE DE PROGESTINE
Publication
Application
Priority
- US 9818850 W 19980909
- US 92853097 A 19970912
Abstract (en)
[origin: WO9913882A1] This invention provides a method of contraception which comprises administering to a female of child bearing age for 28 days per menstrual cycle a combination of a progestin at a daily dosage equivalent to 30-150 mu g levornorgestrel and an estrogen at a daily dosage equivalent to 10-20 mu g ethinyl estradiol for 23-25 days beginning on day 1 of the menstrual cycle, followed by administering a progestin at a daily dosage equivalent to 10-100 mu g levornorgestrel for 3-5 days.
IPC 1-7
IPC 8 full level
A61K 31/565 (2006.01); A61K 31/57 (2006.01); A61P 15/18 (2006.01)
CPC (source: EP)
A61K 31/565 (2013.01); A61K 31/567 (2013.01); A61P 15/18 (2017.12)
Citation (search report)
See references of WO 9913882A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9913882 A1 19990325; AU 759925 B2 20030501; AU 9228698 A 19990405; CA 2301162 A1 19990325; CN 1270521 A 20001018; EP 1011681 A1 20000628; JP 2001516720 A 20011002
DOCDB simple family (application)
US 9818850 W 19980909; AU 9228698 A 19980909; CA 2301162 A 19980909; CN 98809067 A 19980909; EP 98944837 A 19980909; JP 2000511503 A 19980909